Pharmacological bioactivity of enzymatically bio-transformed ginsenosides
)Abstract
Many ginsenosides have shown positive effects, including anti-cancer potential and anti-inflammatory effects. Of note, protopanaxadiol (PPD) and protopanaxatriol (PPT) are not easily absorbed by the body through the digestive tract due to their hydrophilicity. From this point of view, the cytotoxic potencies of the hydrolysates of PPD and PPT on CRC are much stronger than their source compounds. Moreover, several minor ginsenosides that are absent naturally but have high disease ameliorative efficacy can be obtained from major ginsenoside by enzymatic hydrolysis. Therefore, the first aim of this study was to determine the effectiveness of the biotransformation of ginsenosides via enzymatic hydrolysis to improve their bioactivity. Second, the anti-inflammatory and anti-cancer effects of the raw and bio-transformed ginseng metabolites were determined in vitro. The results suggest that enzymes can effectively biotransform major ginsenosides (i.e., PPD and PPT) into minor ginsenosides (i.e., compound K) by hydrolyzing the β-glucosidic linkage. Moreover, the bio-transformed ginsenosides were effective in inhibiting the proliferation of HCT-116 cells and suppressing lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophages. Therefore, the enzymatic hydrolysis of ginsenosides can be employed to functionally produce hydrolysates with increased bioactivity.
References
Ahn, S., Siddiqi, M.H., Noh, H.-Y., Kim, Y.-J., Kim, Y.-J., Jin, C.-G., and Yang, D.-C. (2015). Anti-inflammatory activity of ginsenosides in LPS-stimulated RAW 264.7 cells. Sci. Bull. 60: 773–784.
Ahuja, A., Kim, J.H., Kim, J.H., Yi, Y.S., and Cho, J.Y. (2018). Functional role of ginseng-derived compounds in cancer. J. Ginseng Res. 42: 248–254.
An, K., Shengjie, Z., Jinjun, S., and Liuqing, D. (2015). Gut microbiota-mediated deglycosylation of ginsenoside Rb 1 in rats: in vitro and in vivo insights from quantitative ultra-performance liquid chromatography-mass spectrometry analysis. Anal. Methods 7: 6173–6181.
Bae, E.A., Han, M.J., Kim, E.J., and Kim, D.H. (2004). Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch. Pharm. Res. 27: 61–67.
Bae, E.A., Park, S.Y., and Kim, D.H. (2000). Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull. 23: 1481–1485.
Boyle, T., Heyworth, J., Bull, F., McKerracher, S., Platell, C., and Fritschi, L. (2011). Timing and intensity of recreational physical activity and the risk of subsite-specific colorectal cancer. Cancer Causes Control 22: 1647–1658.
Chen, X.J., Zhang, X.J., Shui, Y.M., Wan, J.B., and Gao, J.L. (2016). Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites. Evid Based Complement Altern. Med. 2016: 5738694.
Corbit, R.M., Ferreira, J.F., Ebbs, S.D., and Murphy, L.L. (2005). Simplified extraction of ginsenosides from American ginseng (Panax quinquefolius L.) for high-performance liquid chromatography-ultraviolet analysis. J. Agric. Food Chem. 53: 9867–9873.
Hagland, H.R., Berg, M., Jolma, I.W., Carlsen, A., and Søreide, K. (2013). Molecular pathways and cellular metabolism in colorectal cancer. Dig. Surg. 30: 12–25.
Kim, D.-H. (2009). Metabolism of ginsenosides to bioactive compounds by intestinal microflora and its industrial application. J. Ginseng Res. 33: 165–176.
Kim, E.H., and Kim, W. (2018). An Insight into Ginsenoside Metabolite Compound K as a Potential Tool for Skin Disorder. Evid Based Complement Altern. Med. 2018: 8075870.
Kim, J.H., Yi, Y.-S., Kim, M.-Y., and Cho, J.Y. (2017). Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J. Ginseng Res. 41: 435–443.
Lasry, A., Zinger, A., and Ben-Neriah, Y. (2016). Inflammatory networks underlying colorectal cancer. Nat. Immunol. 17: 230–240.
Lee, J.I., Ha, Y.W., Choi, T.W., Kim, H.J., Kim, S.M., Jang, H.J., Choi, J.H., Choi, M.H., Chung, B.C., Sethi, G., Kim, S.H., Ahn, K.S., Choi, S.H., Shim, B.S., and Ahn, K.S. (2011). Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells. Planta Med. 77: 133–140.
Leung, K.W., and Wong, A.S. (2010). Pharmacology of ginsenosides: a literature review. Chin. Med. 5: 20.
Liu, C.Y., Zhou, R.X., Sun, C.K., Jin, Y.H., Yu, H.S., Zhang, T.Y., Xu, L.Q., and Jin, F.X. (2015). Preparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-Ⅰ from Aspergillus niger g. 848. J. Ginseng Res. 39: 221–229.
Liu, J., Nile, S.H., Xu, G., Wang, Y., and Kai, G. (2021). Systematic exploration of Astragalus membranaceus and Panax ginseng as immune regulators: Insights from the comparative biological and computational analysis. Phytomedicine 86: 153077.
Mao, Q., Zhang, P.H., Wang, Q., and Li, S.L. (2014). Ginsenoside F(2) induces apoptosis in humor gastric carcinoma cells through reactive oxygen species-mitochondria pathway and modulation of ASK-1/JNK signaling cascade in vitro and in vivo. Phytomedicine 21: 515–522.
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., and Rodriguez Yoldi, M.J. (2017). Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int. J. Mol. Sci. 18: 197.
Martín, R., Hernández, M., Córdova, C., and Nieto, M. L. (2012). Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. Br. J. Pharmacol. 166: 1708–1723
Narasimha, G., Sridevi, A., Ramanjaneyulu, G., and Rajasekhar Reddy, B. (2016). Purification and Characterization of β-Glucosidase from Aspergillus niger. Int. J. Food Prop. 19: 652–661.
Pan, S.Y., Litscher, G., Gao, S.H., Zhou, S.F., Yu, Z.L., Chen, H.Q., Zhang, S.F., Tang, M.K., Sun, J.N., and Ko, K.M. (2014). Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evid Based Complement Altern. Med. 2014: 525340.
Søreide, K. (2007). Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time? Tumour Biol. 28: 290–300.
Saba, E., Jeong, D., Irfan, M., Lee, Y.Y., Park, S.J., Park, C.K., and Rhee, M.H. (2018). Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis. Evid Based Complement Altern. Med. 2018: 6874692.
Seo, E.Y., and Kim, W.K. (2011). Red ginseng extract reduced metastasis of colon cancer cells in vitro and in vivo. J. Ginseng Res. 35: 315–324.
Shahrajabian, M.H., Sun, W., and Cheng, Q. (2019). A review of ginseng species in different regions as a multipurpose herb in traditional Chinese medicine, modern herbology and pharmacological science. J. Med. Plants Res. 13: 213–226.
Shim, S.H., Baek, K.-H., and Kim, Y.-S. (2009). Inhibition of human 20S proteasome by ginsenosides from Panax ginseng. Bull. Korean Chem. Soc. 30: 1385–1387.
Siegel, R.L., Miller, K.D., Fuchs, H.E., and Jemal, A. (2021). Cancer Statistics, 2021. Ca-Cancer J. Clin. 71: 7–33.
Singh, G., Verma, A.K., and Kumar, V. (2016). Catalytic properties, functional attributes and industrial applications of β-glucosidases. 3 Biotech 6: 3.
Wan, J.B., Lee, S.M., Wang, J.D., Wang, N., He, C.W., Wang, Y.T., and Kang, J.X. (2009). Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion. J. Agric. Food Chem. 57: 6692–6697.
Yan, Q., Zhou, X.W., Zhou, W., Li, X.W., Feng, M.Q., and Zhou, P. (2008). Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces Bainier. J. Microbiol. Biotechnol. 18: 1081–1089.
Yan, T.R., Lin, Y.H., and Lin, C.L. (1998). Purification and Characterization of an Extracellular beta-Glucosidase Ⅱ with High Hydrolysis and Transglucosylation Activities from Aspergillus niger. J. Agric. Food Chem. 46: 431–437.
Yue, P.Y., Mak, N.K., Cheng, Y.K., Leung, K.W., Ng, T.B., Fan, D.T., Yeung, H.W., and Wong, R.N. (2007). Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin. Med. 2: 6.
Zhang, H., Abid, S., Ahn, J.C., Mathiyalagan, R., Kim, Y.J., Yang, D.C., and Wang, Y. (2020). Characteristics of Panax ginseng Cultivars in Korea and China. Molecules 25: 2635.
京公网安备11010802044758号